Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithotomy (PNL)

Akshay Kriplani, Shruti Pandit, Arun Chawla, Jean J M C H de la Rosette, Pilar Laguna, Suraj Jayadeva Reddy, Bhaskar K Somani, Akshay Kriplani, Shruti Pandit, Arun Chawla, Jean J M C H de la Rosette, Pilar Laguna, Suraj Jayadeva Reddy, Bhaskar K Somani

Abstract

The objective of this prospective observational study was to assess the clinical significance of neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) as potential biomarkers to identify post-PNL SIRS or sepsis. Demographic data and laboratory data including hemoglobin (Hb), total leucocyte count (TLC), serum creatinine, urine microscopy and culture were collected. The NLR, LMR and PLR were calculated by the mathematical division of their absolute values derived from routine complete blood counts from peripheral blood samples. Stone factors were assessed by non-contrast computerized tomography of kidneys, ureter and bladder (NCCT KUB) and included stone burden (Volume = L × W × D × π × 0.167), location and Hounsfield value and laterality. Intraoperative factors assessed were puncture site, tract size, tract number, operative time, the need for blood transfusion and stone clearance. Of 517 patients evaluated, 56 (10.8%) developed SIRS and 8 (1.5%) developed sepsis. Patients developing SIRS had significantly higher TLC (10.4 ± 3.5 vs 8.6 ± 2.6, OR 1.19, 95% CI 1.09-1.3, p = 0.000002), higher NLR (3.6 ± 2.4 vs 2.5 ± 1.04, OR 1.3, 95% CI = 1.09-1.5, p = 0.0000001), higher PLR (129.3 ± 53.8 vs 115.4 ± 68.9, OR 1.005, 95% CI 1.001-1.008, p = 0.005) and lower LMR (2.5 ± 1.7 vs 3.2 ± 1.8, OR 1.18, 95% CI 1.04-1.34, p = 0.006). Staghorn stones (12.8 vs 3.24%, OR 4.361, 95% CI 1.605-11.846, p = 0.008) and long operative times (59.6 ± 14.01 vs 55.2 ± 16.02, OR 1.01, 95% CI 1.00-1.03, p = 0.05) had significant association with postoperative SIRS. In conclusion, NLR, PLR and LMR can be useful independent, easily accessible and cost-effective predictors for early identification of post-PNL SIRS/sepsis.

Keywords: Endourology; PCNL; Renal stones; SIRS; Sepsis.

Conflict of interest statement

The authors declared that they have no conflict of interest.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Receiver operating characteristic (ROC) curve analysis results of NLR, PLR and LMR in predicting postoperative SIRS
Fig. 2
Fig. 2
Receiver operating characteristic (ROC) curve analysis results of NLR, PLR and LMR in predicting postoperative sepsis

References

    1. Türk C, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M, Knoll T. EAU guidelines on interventional treatment for urolithiasis. Eur Urol. 2016;69(3):475–482. doi: 10.1016/j.eururo.2015.07.041.
    1. De La Rosette J, Denstedt J, Geavlete P, Keeley F, Matsuda T, Pearle M, CROES URS study group The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014;28(2):131–139. doi: 10.1089/end.2013.0436.
    1. Michel MS, Trojan L, Rassweiler JJ. Complications in percutaneous nephrolithotomy. Eur Urol. 2007;51(4):899–906. doi: 10.1016/j.eururo.2006.10.020.
    1. Bansal SS, Pawar PW, Sawant AS, Tamhankar AS, Patil SR, Kasat GV. Predictive factors for fever and sepsis following percutaneous nephrolithotomy: a review of 580 patients. Urol Ann. 2017;9(3):230. doi: 10.4103/UA.UA_166_16.
    1. Fuller A, Razvi H, Denstedt JD, Nott L, Hendrikx A, Luke M, de la Rosette J. The clinical research office of the endourological society percutaneous nephrolithotomy global study: outcomes in the morbidly obese patient—a case control analysis. Canad Urol Assoc J. 2014;8(5–6):E393. doi: 10.5489/cuaj.2258.
    1. Omar M, Noble M, Sivalingam S, El Mahdy A, Gamal A, Farag M, Monga M. Systemic inflammatory response syndrome after percutaneous nephrolithotomy: a randomized single-blind clinical trial evaluating the impact of irrigation pressure. J Urol. 2016;196(1):109–114. doi: 10.1016/j.juro.2016.01.104.
    1. Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol. 2005;173(5):1610–1614. doi: 10.1097/01.ju.0000154350.78826.96.
    1. Dogan HS, Guliyev F, Cetinkaya YS, Sofikerim M, Ozden E, Sahin A. Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol. 2007;39(3):737–742. doi: 10.1007/s11255-006-9147-9.
    1. Jou YC, Lu CL, Chen FH, Shen CH, et al. Contributing factors for fever after tubeless percutaneous nephrolithotomy. Urology. 2015;85(3):527–530. doi: 10.1016/j.urology.2014.10.032.
    1. Koras O, Bozkurt IH, Yonguc T, et al. Risk factors for postoperative infectious complications following percutaneous nephrolithotomy: a prospective clinical study. Urolithiasis. 2015;43(1):55–60. doi: 10.1007/s00240-014-0730-8.
    1. Kreydin EI, Eisner BH. Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol. 2013;10(10):598–605. doi: 10.1038/nrurol.2013.183.
    1. De La Rosette JJ, Opondo D, Daels FP, Giusti G, Serrano A, Kandasami SV, Croes Pcnl Study Group Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol. 2012;62(2):246–255. doi: 10.1016/j.eururo.2012.03.055.
    1. Levy MM, Fink MP, Marshall JC, et al. 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference. Intensive Care Med. 2003;29(4):530–538. doi: 10.1007/s00134-003-1662-x.
    1. Seitz C, Desai M, Häcker A, Hakenberg OW, Liatsikos E, Nagele U, Tolley D. Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol. 2012;61(1):146–158. doi: 10.1016/j.eururo.2011.09.016.
    1. Sen V, Bozkurt IH, Aydogdu O, Yonguc T, et al. Significance of preoperative neutrophil–lymphocyte count ratio on predicting postoperative sepsis after percutaneous nephrolithotomy. Kaohsiung J Med Sci. 2016;32(10):507–513. doi: 10.1016/j.kjms.2016.08.008.
    1. Chen L, Xu QQ, Li JX, Xiong LL, Wang XF, Huang XB. Systemic inflammatory response syndrome after percutaneous nephrolithotomy: an assessment of risk factors. Int J Urol. 2008;15(12):1025–1028. doi: 10.1111/j.1442-2042.2008.02170.x.
    1. Erdil T, Bostanci Y, Ozden E, Atac F, Yakupoglu YK, Yilmaz AF, Sarikaya S. Risk factors for systemic inflammatory response syndrome following percutaneous nephrolithotomy. Urolithiasis. 2013;41(5):395–401. doi: 10.1007/s00240-013-0570-y.
    1. Cetinkaya M, Buldu I, Kurt O, Inan R. Platelet-to-lymphocyte ratio: a new factor for predicting systemic inflammatory response syndrome after percutaneous nephrolithotomy. Urol J. 2017;14(5):4089–4093.
    1. Desai M, De Lisa A, Turna B, Rioja J, On behalf of the CROES PCNL Study Group et al. The clinical research office of the endourological society percutaneous nephrolithotomy global study: staghorn versus nonstaghorn stones. J Endourol. 2011;25(8):1263–1268. doi: 10.1089/end.2011.0055.
    1. McALEER IM, Kaplan GW, Bradley JS, Carroll SF, Griffith DP. Endotoxin content in renal calculi. J Urol. 2003;169(5):1813–1814. doi: 10.1097/01.ju.0000061965.51478.79.
    1. Rao PN, Dube DA, Weightman NC, Oppenheim BA, Morris J. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol. 1991;146(4):955–960. doi: 10.1016/S0022-5347(17)37974-0.
    1. Kajander EO, Çiftçioglu N. Nanobacteria: an alternative mechanism for pathogenic intra-and extracellular calcification and stone formation. Proc Natl Acad Sci. 1998;95(14):8274–8279. doi: 10.1073/pnas.95.14.8274.
    1. Çiftçioglu N, Björklund M, Kuorikoski K, Bergström K, Kajander EO. Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 1999;56(5):1893–1898. doi: 10.1046/j.1523-1755.1999.00755.x.
    1. de Martino M, Pantuck AJ, Hofbauer S, Waldert M, Shariat SF, Belldegrun AS, Klatte T. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. J Urol. 2013;190(6):1999–2004. doi: 10.1016/j.juro.2013.06.082.
    1. Kantola T, Klintrup K, Väyrynen JP, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer. 2012;107(10):1729–1736. doi: 10.1038/bjc.2012.456.
    1. Van Soest RJ, Templeton AJ, Vera-Badillo FE, et al. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Ann Oncol. 2015;26(4):743–749. doi: 10.1093/annonc/mdu569.
    1. Ozyalvacli ME, Ozyalvacli G, Kocaaslan R, Cecen K, Uyeturk U, Kemahlı E, Gucuk A. Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer. Can Urol Assoc J. 2015;9(3–4):E126. doi: 10.5489/cuaj.2523.
    1. Bahadır A, Baltacı D, Türker Y, et al. Is the neutrophil-to-lymphocyte ratio indicative of inflammatory state in patients with obesity and metabolic syndrome? Anatol J Cardiol. 2015;15(10):816. doi: 10.5152/akd.2014.5787.
    1. Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, Iyisoy A. The relation between atherosclerosis and the neutrophil–lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22(5):405–411. doi: 10.1177/1076029615569568.
    1. Verdoia M, Schaffer A, Barbieri L, Aimaretti G, Marino P, Sinigaglia F, Novara Atherosclerosis Study Group Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease. Diabetes Metab. 2015;41(4):304–311. doi: 10.1016/j.diabet.2015.01.001.
    1. Yasar Z, Buyuksirin M, Ucsular FD, et al. Is an elevated neutrophil-to-lymphocyte ratio a predictor of metabolic syndrome in patients with chronic obstructive pulmonary disease. Eur Rev Med Pharmacol Sci. 2015;19(6):956–962.
    1. Buyukkaya E, Karakaş MF, Karakaş E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2014;20(2):159–163. doi: 10.1177/1076029612459675.
    1. Mao W, Wu J, Zhang Z, Xu Z, Xu B, Chen M. Neutrophil-lymphocyte ratio acts as a novel diagnostic biomarker for kidney stone prevalence and number of stones passed. Transl Androl Urol. 2021 doi: 10.21037/tau-20-890.
    1. Tang K, Liu H, Jiang K, Ye T, et al. Predictive value of preoperative inflammatory response biomarkers for metabolic syndrome and post-PCNL systemic inflammatory response syndrome in patients with nephrolithiasis. Oncotarget. 2017;8(49):85612. doi: 10.18632/oncotarget.20344.
    1. Fujii Y, Okada A, Yasui T, Niimi K, et al. Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis. PLoS ONE. 2013;8(4):e61343. doi: 10.1371/journal.pone.0061343.
    1. Petrie HT, Klassen LW, Kay HD. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol. 1985;134(1):230–234.
    1. Gasparyan AY, Ayvazyan L, Mukanova U, Yessirkepov M, Kitas GD. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39(4):345–357. doi: 10.3343/alm.2019.39.4.345.
    1. Lee JS, Kim NY, Na SH, Youn YH, Shin CS. Reference values of neutrophil-lymphocyte ratio, lymphocyte–monocyte ratio, platelet–lymphocyte ratio, and mean platelet volume in healthy adults in South Korea. Medicine. 2018 doi: 10.1097/MD.0000000000011138.
    1. Xu H, Hu L, Wei X, Niu J, Gao Y, He J, Hou J. The predictive value of preoperative high-sensitive C-reactive protein/albumin ratio in systemic inflammatory response syndrome after percutaneous nephrolithotomy. J Endourol. 2019;33(1):1–8. doi: 10.1089/end.2018.0632.
    1. Aghdas FS, Akhavizadegan H, Aryanpoor A, Inanloo H, Karbakhsh M. Fever after percutaneous nephrolithotomy: contributing factors. Surg Infect. 2006;7(4):367–371. doi: 10.1089/sur.2006.7.367.
    1. Liu C, Zhang X, Liu Y, Wang P. Prevention and treatment of septic shock following mini-percutaneous nephrolithotomy: a single-center retrospective study of 834 cases. World J Urol. 2013;31(6):1593–1597. doi: 10.1007/s00345-012-1002-2.
    1. Rivera M, Viers B, Cockerill P, Agarwal D, Mehta R, Krambeck A. Pre-and postoperative predictors of infection-related complications in patients undergoing percutaneous nephrolithotomy. J Endourol. 2016;30(9):982–986. doi: 10.1089/end.2016.0191.
    1. Gonen M, Turan H, Ozturk B, Ozkardes H. Factors affecting fever following percutaneous nephrolithotomy: a prospective clinical study. J Endourol. 2008;22(9):2135–2138. doi: 10.1089/end.2008.0139.
    1. Ganesan V, Brown RD, Jimenez JA, De S, Monga M. C-reactive protein and erythrocyte sedimentation rate predict systemic inflammatory response syndrome after percutaneous nephrolithotomy. J Endourol. 2017;31(7):638–644. doi: 10.1089/end.2016.0884.
    1. Zheng J, Li Q, Fu W, Ren J, et al. Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis. 2015;43(1):41–47. doi: 10.1007/s00240-014-0716-6.
    1. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5–14.
    1. Terradas R, Grau S, Blanch J, Riu M, Saballs P, Castells X, Horcajada JP, Knobel H. Eosinophil count and neutrophil-lymphocyte count ratio as prognostic markers in patients with bacteremia: a retrospective cohort study. PloS one. 2012;7(8):e42860. doi: 10.1371/journal.pone.0042860.
    1. de Jager CP, van Wijk PT, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Crit Care. 2010;14(5):1–8. doi: 10.1186/cc9309.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner